Skip to content

Effectiveness of orthodontic mini-implant covers

Clinical assessment of orthodontic mini-implant covers and their effect on oral health quality of life: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN93152504
Enrollment
39
Registered
2020-05-06
Start date
2017-11-10
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral health (orthodontic) Oral Health

Interventions

The patients will be allocated randomly by stratified block randomisation. Recruited patients will be active orthodontic patients that require orthodontic mini implants (MIs) as part of their orthodon
T1 (1 hour after MI insertion)
T12 (12 Hours after MI insertion)
T24 (24 hours after MI insertion)
TD2 (2 days after MI insertion)
TD3 (3 days after MI insertion)
TD7 (7 days after MI insertion)
TD14 (14days after MI insertion) and TD30 (30 days after MI insertion).

Sponsors

Universiti Teknologi MARA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Orthodontic patients requiring MI placement as part of anchorage reinforcement of their orthodontic treatment 2. Age 18 years up to 30 years old 3. Healthy patients with no underlying systemic diseases or illness 4. Requiring posteriorly and buccally placed MI on the maxilla or mandible (distal to the canines) 5. Healthy periodontium and good oral hygiene

Exclusion criteria

Exclusion criteria: 1. Pre-existing oral soft tissue conditions (such as Recurrent Apthous Stomatitis) 2. Previously failed MI or reinsertion of MI 3. On medications that may alter the oral health status 4. Underlying medical conditions such as diabetes 5. Cleft lip and palate patients 6. Smokers 7. Allergies to metals such as stainless steel or titanium

Design outcomes

Primary

MeasureTime frame
Pain score (Numeric Rating Scale) at T0-TD30 at B0 (baseline- before MI insertion for Control group) and T0 (immediately after MI insertion fr SF and CR groups); T1 (1 hour after MI insertion); T12 (12 Hours after MI insertion); T24 (24 hours after MI insertion); TD2 (2 days after MI insertion); TD3 (3 days after MI insertion); TD7 (7 days after MI insertion); TD14 (14days after MI insertion) and TD30 (30 days after MI insertion)

Secondary

MeasureTime frame
1. Oral health-related quality of life using the Modified Short Oral Health Impact profile -14 (at T0 and TD30) 2. Cost-Effectiveness of the MI covers calculated by comparing the current the cost of each material (per syringe) and the amount of MI covers that are produced by a single syringe

Countries

Malaysia

Contacts

Public ContactNor Dayana Mohd Ali
nordayana03@gmail.com+601116670700

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026